Why the study?
Does low LV mass (cardiac wasting) predict poor functional status and increased all-cause mortality in patients with advanced cancer?
Does low LV mass (cardiac wasting) predict poor functional status and increased all-cause mortality in patients with advanced cancer?
Low LV mass provides clinical evidence of a cardiac wasting-associated cardiomyopathy that worsens prognosis and functional status in advanced cancer.
May support LV mass for risk stratification in advanced cancer; hypothesis-generating and requires prospective validation before practice change.
Low LV mass is associated with poor functional status and increased all-cause mortality in cancer. These findings provide clinical evidence of cardiac wasting-associated cardiomyopathy in cancer.
No takes yet. Share an insight, caveat, or question.
Lena et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: